"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're delivering the care you need. Mayo Clinic follows carefully designed, rigorously enforced safety precautions for anyone who needs face-to-face care. We're safely treating all patients, both in person and through virtual visits, in adherence with federal and state executive orders and guidance. With highly ranked teams of surgeons and specialists, Mayo Clinic provides care for people who need transplants of the heart, lung, liver, kidney, pancreas, and blood and bone marrow as treatment for complex or rare disorders."

During the past decade, Mayo Clinic Transplant Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic Transplant Center" #1 collaborator was "Novartis" with 2 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic Transplant Center" are "Chronic Hepatitis C" (2 trials), "Kidney Transplant Failure" (2 trials), "Graft Rejection" (1 trials), "Heart Disease" (1 trials) and "Ischemic Heart Disease" (1 trials). Many other conditions were trialed in "Mayo Clinic Transplant Center" in a lesser frequency.

Most popular intervention types in "Mayo Clinic Transplant Center" are "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (2 trials), "Ribavirin" (2 trials), "albumin interferon alfa-2b" (2 trials), "peginterferon alfa-2a" (2 trials) and "Non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic Transplant Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Mayo Clinic Transplant Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mayo Clinic Transplant Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic Transplant Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".